<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01995760</url>
  </required_header>
  <id_info>
    <org_study_id>201310037RINA</org_study_id>
    <nct_id>NCT01995760</nct_id>
  </id_info>
  <brief_title>The Most Appropriate Parameter Correlates With Clinical Effectiveness of Vancomycin: Trough Drug Concentration or Area Under Curve (AUC)/Minimum Inhibitory Concentration (MIC)?</brief_title>
  <official_title>The Most Appropriate Parameter Correlates With Clinical Effectiveness of Vancomycin: Trough Drug Concentration or Area Under Curve (AUC)/Minimum Inhibitory Concentration (MIC)?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate which is the most appropriate parameter correlates&#xD;
      with clinical effectiveness of vancomycin: trough drug level or AUC/MIC.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several studies have shown AUC/MIC to be the better pharmacokinetic-pharmacodynamic parameter&#xD;
      for clinical effectiveness of vancomycin. However, the 2009 consensus guideline for&#xD;
      vancomycin therapeutic monitoring continued to recommend trough serum concentration&#xD;
      monitoring in the clinical setting. In 2011, Patel et al showed that highly difference&#xD;
      between AUC(72-96h) and Cmin(96h). Different dosing and creatinine clearance may reach the&#xD;
      same trough drug level with different AUC. The investigators wonder whether trough drug level&#xD;
      can serve as a substitute marker for AUC and as a parameter for vancomycin therapeutic&#xD;
      monitoring.&#xD;
&#xD;
      In this study, the investigators will calculate AUC/MIC of vancomycin with published formula,&#xD;
      analyze its correlation with patient's clinical outcome and compare that with trough drug&#xD;
      level.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>30-day mortality</measure>
    <time_frame>Day 30 after index date (the date of positive methicillin-resistant Staphylococcus aureus blood culture)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>90-day mortality</measure>
    <time_frame>Day 90 after index date (the date of positive methicillin-resistant Staphylococcus aureus blood culture)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital mortality</measure>
    <time_frame>Discharge day</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">123</enrollment>
  <condition>Methicillin-resistant Staphylococcus Aureus Septicemia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Inpatients of National Taiwan University Hospital. During the period of 2001/1/1 to&#xD;
        2013/12/31, age above or equal to 20 year-old adult with positive methicillin-resistant&#xD;
        Staphylococcus aureus blood culture who receiving vancomycin therapy with therapeutic&#xD;
        monitoring.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Inpatients of National Taiwan University Hospital&#xD;
&#xD;
          -  Age above or equal to 20 years old&#xD;
&#xD;
          -  Positive methicillin-resistant Staphylococcus aureus blood culture&#xD;
&#xD;
          -  Receiving vancomycin therapy for definitive use&#xD;
&#xD;
          -  Undergoing therapeutic drug monitoring (had serum vancomycin concentration level)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age below 20 years old&#xD;
&#xD;
          -  Without details of vancomycin dose and frequency&#xD;
&#xD;
          -  Vancomycin treatment shorter than 72 hours&#xD;
&#xD;
          -  Without renal function data (serum creatinine level, creatinine clearance)&#xD;
&#xD;
          -  Without infection-related clinical outcomes (lab data such as white blood cell count ,&#xD;
             seg, C reactive protein , body temperature records)&#xD;
&#xD;
          -  Receiving renal replacement therapy&#xD;
&#xD;
          -  Therapeutic drug monitoring before reaching steady state&#xD;
&#xD;
          -  With abnormal and undefined serum concentration&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Li-Jiuan Shen</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <study_first_submitted>November 10, 2013</study_first_submitted>
  <study_first_submitted_qc>November 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 27, 2013</study_first_posted>
  <last_update_submitted>September 2, 2014</last_update_submitted>
  <last_update_submitted_qc>September 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vancomycin</keyword>
  <keyword>therapeutic response monitoring</keyword>
  <keyword>AUC/MIC</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

